Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Hedge-fund investor who made $2.6 billion on pandemic trades says omicron could be bullish for stock market

by
November 29, 2021
in Trading News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Hedge-fund luminary Bill Ackman over the weekend said the new omicron variant of the coronavirus that causes COVID-19 could be bullish for stocks if it proves to result in mild to moderate symptoms for those who contract it.

The discovery of the variant resulted in one of the worst Black Friday trading sessions in recent memory, with the Dow Jones Industrial Average
DJIA,
+1.03%
,
the S&P 500 index
SPX,
+1.70%

and the Nasdaq Composite Index
COMP,
+2.19%

all tumbling by at least 2%, but Ackman’s comments suggest that investors’ knee-jerk response may have been an overreaction.

RELATED POSTS

Options Prop Trading Firm Reviews & Ratings: Where Should You Invest?

Stock Analysis Website Reviews & Ratings: Navigating the Best Options for Investors

Bond yields on Friday also fell as prices for government debt saw a rush to the perceived safety of Treasurys on the back of fresh concerns about new restrictions that could result from a strain of COVID that the World Health Organization on Friday designated a variant of concern.

However, stocks were bouncing back on Monday and the 10-year Treasury note yield
TMUBMUSD10Y,
1.526%

was up 8 basis points at 1.56%. Prices for Treasurys fall as yields rise.

Ackman, who runs Pershing Square Capital, is known for his lucrative COVID wager. The Financial Times reported back in 2020 that the investor cashed out on bet that netted him a $2.6 billion profit on a $27 million at risk, on the premise that insurance premiums would soar during the height of the 2020 COVID pandemic as economies locked down.

He also later in 2020 said that he placed bearish bets on corporate credit on the day that Pfizer
PFE,
-0.25%

 and BioNTech
BNTX,
+4.14%

released positive trial data on their COVID-19 vaccine, which triggered a whipsaw rally in stocks.

Ackman was wagering that the vaccines would lead to mask-wearing complacency. However, that bet presumably turned out wrong as markets continued to surge in the aftermath of those vaccines.

The danger posed by the omicron variant isn’t yet fully understood, even though governments in Europe, Asia, the Middle East and the Americas immediately restricted travel from southern Africa.

Vaccine manufacturers have said that they are examining the variant closely and note that the current batch of remedies might still prove effective against the strain and new vaccines could be readied in early 2022 if needed.

ShareTweetPin

Related Posts

Options Prop Trading Firm Reviews & Ratings: Where Should You Invest?

by
September 23, 2023
0

Options prop trading involves buying and selling options contracts to generate profits, typically within a firm that provides the capital...

Stock Analysis Website Reviews & Ratings: Navigating the Best Options for Investors

by
September 23, 2023
0

With the growing complexity of the stock market and increasing investment options, it’s crucial to have accurate and timely information...

Stock Chat Room Reviews & Ratings: Unveiling the Best Options

by
September 23, 2023
0

Stock chat rooms have become indispensable tools in the toolkits of modern traders. In these digital spaces, traders of all...

Options Trading Alert Service Reviews & Ratings: What You Need to Know

by
September 23, 2023
0

Options trading alert services are crucial for any modern options trader. These services offer traders valuable insights, real-time alerts, and...

Stock Charting App Reviews & Ratings: Navigating the Best Options for Traders

by
September 23, 2023
0

Stock charting apps are vital for traders, investors, and market analysts. These specialized software platforms offer a range of features,...

Next Post

Stocks making the biggest moves midday: Twitter, Moderna, Merck, Tesla and more

S&P 500 hits high of session, up 1.5% after Biden says Covid lockdowns not needed for now

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net